Raviteja Devalla, MD
Vascular Surgery · Dakota Dunes, SDNPI 1073975298
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,733 of the $8,719 with a category attached, or 88.7%. 32 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 29.3% of the total.
Across 160 payments — averaging $54.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$3K
- Inari Medical, Inc.$2K
- Medtronic$2K
- Stryker$401
- Argon Medical Devices, Inc.$323
- Boston Scientific$295
- plus $2K from 26 others
What the payments were for
- Travel & lodging$2403%
- Food & beverage$7,73389%
- Education$7469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 32 | $2,557 |
| Inari Medical, Inc. | 23 | $1,673 |
| Medtronic | 30 | $1,672 |
| Stryker | 4 | $401 |
| Argon Medical Devices, Inc. | 3 | $323 |
| Boston Scientific | 14 | $295 |
| Acell, Inc. | 5 | $252 |
| Integra Lifesciences Corporation | 5 | $207 |
| Angiodynamics, Inc. | 3 | $194 |
| Silk Road Medical, Inc. | 1 | $120 |
| Asahi Intecc USA, Inc. | 1 | $103 |
| Reflow Medical Inc | 1 | $82 |
| Johnson & Johnson(3 entities) | 5 | $82 |
| Avanos Medical | 4 | $71 |
| Abiomed | 1 | $66 |
| AbbVie | 3 | $66 |
| CSL Behring | 3 | $64 |
| Zimmer Biomet | 1 | $62 |
| Baxter Healthcare | 4 | $57 |
| Polarityte, Inc. | 1 | $42 |
| Chiesi USA, Inc. | 2 | $40 |
| Pfizer | 3 | $39 |
| Penumbra, Inc. | 1 | $38 |
| Portola Pharmaceuticals, LLC | 1 | $32 |
| Cardiovascular Systems Inc. | 1 | $31 |
| Smith+Nephew | 2 | $29 |
| Edwards Lifesciences | 1 | $26 |
| Kerecis Limited | 1 | $25 |
| KCI USA, Inc. | 1 | $21 |
| Kls-martin L.p. | 1 | $18 |
| Davol Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$1,176
- FLOWTRIEVER CATHETER, S$773
- CT THROMBECTOMY SYSTEM KIT$773
- TurboHawk$544
- GORE EXCLUDER AAA Endoprosthesis$434
- GORE-TEX Vascular Graft$312
- CYTAL$261
- ENROUTE Transcarotid Neuroprotection System$239
- CLEANER$191
- HawkOne$175
- IN.PACT Admiral$144
- FlowTriever$133
- Auryon Laser System 100-120 Vac$129
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$120
- ENROUTE Transcarotid Stent$120
- Clot Management$115
- ENDURANT IIS$109
- PERIPHERAL VASCULAR$103
How this compares
Too few vascular surgery providers in South Dakotato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 96 | $40,688 |
| EliquisApixaban | 43 | $34,673 |
| ClopidogrelClopidogrel Bisulfate | 91 | $684 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 83 | $479 |
| Atorvastatin Calcium | 31 | $206 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $82 | $40,68896 claims |
| PfizerEliquis | $39 | $34,67343 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few vascular surgery providers in South Dakotaon file to place this against a meaningful peer group, so we don't.
Other vascular surgery in Dakota Dunes
- Chad LaurichDakota Dunes$94K
- Arthelma TysonDakota Dunes$5K
- Frank VandySioux Falls$104K
- Mark FlemingSioux Falls$55K
- Anand DayamaSioux Falls$38K
- Thekla BacharachSioux Falls$24K
- Gregory NissenSioux Falls$15K
- Patrick KellySioux Falls$14K
- Angelo SantosSioux Falls$7K
- Bradley SwedaSioux Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.